Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Raguu17on Jan 23, 2019 1:46pm
41 Views
Post# 29271630

RE:RE:RE:RE:RE:ACB Positive EBITDA BY Q3!!

RE:RE:RE:RE:RE:ACB Positive EBITDA BY Q3!!

Retail looks to share price. Share price is the currency of choice used by management. You would think we have the same objective. no? Management literally devalues their own currency without showing value before doing it again. Slowing down? They are in the middle of several deals right now. They just got another 300 million.

They reason I mention the retail investor is thats who these two blame for their poor share value. They fail to mention that we are consistantly in the top 10 shorted stock. Thats retail? More likely these apparent instituional investors.

Their "strategy" has been to use shares and be the highest bidder (offer largest premium). This has reduced their currencies value. This reduces their ability to aquire anything of value. Without us lowly retail people their strategy isn't worth much. It depended on our support. 

Cam was doing damage control in his last Midas interview. Terry's last interview he sounded all pouty that the market hasn't just blindly followed his crudely discribe path. He hasn't represented Aurora professionally at all. This reduces confidence. He shouldn't ever speak to the public. 

He has made us a target. Not in a good way either. APHA was campaign shorted. Accused of all kinds of things. Run down substantially. Then targetted for a takeover. We have been hit harder. We are shorted harder. That is a fine job? These shorts feed on weakness. Having your CEO publically state his aggressive dilutive "strategy" over and over again invited this situation.

We have production to rival WEED, we distribution to rival WEED yet our CAP is a fraction. That is how well these two have comminucated their vision. 

They couldn't even explain the 300 milly was a good deal. They couldn't point to the $7.30US share price this deal allowed them in at. Or the reasonable 5.5%. The reasons for the raise were as vague as it gets. Everything from further expansion to operations. They mind as well have said "stuff". 

Their communication is piss poor. Their SP reflects this. 

 





40hourweak wrote:

Raguu17 wrote: So the answer is no you haven't heard anything from anyone of any pull. You have a theory and a hope. Cool.

This theory relies on Booth caring about shareholders. Has this been his history? Please provide examples. Maybe I forgot but I can't think of one time. In fact I can think of a few where he tanked us with his verbalized opinion. Battley blames the tanking on "retail". Thats how much they value us. 

The fact is Booth's total lack of give a fvck towards his lowly retail investors is what is hurting us. 




foxxy113 wrote:
Last paragraph says it all! EBITDA Share Earnings before interest, taxes, depreciation and amortization (EBITDA) is the primary calculation used to determine how much of a companys cash flow comes from ongoing operations. It is an important indicator of the health of a business. EBITDA is calculated from contents of the income statement using the following formula: Net profit + interest + taxes + depreciation + amortization EBITDA can be either positive or negative. A business is considered healthy when its EBITDA is positive for a prolonged period of time. Even profitable businesses, however, can experience short periods of negative EBITDA. Bankers and other finance professionals use EBITDA to decide how much money they are willing to lend a company. They may use other measures as well, but EBITDA is one of the strongest and most consistent measures. EBITDA is also used to: Help determine the value of a company Assess a companys ability to pay its debts Determine the ability of a business to generate surpluses for activities like paying dividends

 


Raguu... any business owner who is worried about his or her retail investors value while in a pure growth and market capture strategy mode would be derelict in his duty. Especially in a new industry where the current climate is basically sink or swim. The aggressive acquisition phase that is admittedly slowing down at this point of s exactly the kind of thing that sets us up for future value accrual.... worrying about shareholder value right now is not a priority and shouldn’t not be a priority at this early stage. There is times for that down the road... and everything they are doing now will add value down the road as the industry matures and companies almagamate... not to mention that there will be deals with pharma/bev/wellness companies coming down the pipe at some point in the near future... it’s simply a matter of time. 

Terry and Cam are doing a fine job. Nothing wrong with their business strategy... 


Bullboard Posts